Abzyme Therapeutics Llc
CAGE Code: 62ES6
NCAGE Code: 62ES6
Status: Discontinued
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 962964990
Summary
Abzyme Therapeutics Llc is a Discontinued Commercial Supplier with the Cage Code 62ES6 and is tracked by Dun & Bradstreet under DUNS Number 962964990..
Address
321 Jones Blvd
Ste 300
Pottstown PA 19464-3468
United States
Points of Contact
No Points of Contact...
Related Information
People who viewed this 'CAGE Code' also viewed...
Automatic Electric Heater Co Matlock Rental Co Fords Trucking Llc J M Walters Co Hill & Bell Associates, Inc. Precision Glass Technologies Buckman's, Inc. Security Products International Inc Engineering Publications Group Blackberry Technologies Nyco Transformer Co M And R Packaging Inc Columbia Boiler Co Of Pottstown Dolbey-Jamison Optical Co., Inc. Chop Rite Mfg Co Inc Science & Technology Research Aero Store Corp Curtiss And Smith Mfg Corp Nofer Fred W And Son Inc Clean Air Consultants Inc
Frequently Asked Questions (FAQ) for CAGE 62ES6
- What is CAGE Code 62ES6?
- 62ES6 is the unique identifier used by NATO Organizations to reference the physical entity known as Abzyme Therapeutics Llc located at 321 Jones Blvd, Ste 300, Pottstown PA 19464-3468, United States.
- Who is CAGE Code 62ES6?
- 62ES6 refers to Abzyme Therapeutics Llc located at 321 Jones Blvd, Ste 300, Pottstown PA 19464-3468, United States.
- Where is CAGE Code 62ES6 Located?
- CAGE Code 62ES6 is located in Pottstown, PA, USA.
Contracting History for CAGE 62ES6 Most Recent 25 Records
- W911QY18C0004
- Option Year - 2
- 17 Jun 2020
- Option Year - 2
- W6qk Acc-Apg Natick
- Department Of Defense (Dod)
- $999,998.10
- Department Of Defense (Dod)
- 75N91018C00031
- Igf::Ot::Igf Project Title: Monoclonal Antibodies To Rna-Modifications
- 6 Nov 2018
- Igf::Ot::Igf Project Title: Monoclonal Antibodies To Rna-Modifications
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $299,999.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00009
- The Objective Of This Contract Is To Develop Camelid Vhhs That Are Capable Of Significantly (At Least 5-Fold Improvement) Enhancing Gp120 Expression In Mammalian Cells And Applicable For Rapid And Scalable Gp120 Protein Purification.
- 11 May 2020
- The Objective Of This Contract Is To Develop Camelid Vhhs That Are Capable Of Significantly (At Least 5-Fold Improvement) Enhancing Gp120 Expression In Mammalian Cells And Applicable For Rapid And Scalable Gp120 Protein Purification.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $299,815.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00009
- The Objective Of This Contract Is To Develop Camelid Vhhs That Are Capable Of Significantly (At Least 5-Fold Improvement)Enhancing Gp120 Expression In Mammalian Cells And Applicable For Rapid And Scalable Gp120 Protein Purification.
- 29 May 2019
- The Objective Of This Contract Is To Develop Camelid Vhhs That Are Capable Of Significantly (At Least 5-Fold Improvement)Enhancing Gp120 Expression In Mammalian Cells And Applicable For Rapid And Scalable Gp120 Protein Purification.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $299,815.00
- Department Of Health And Human Services (Hhs)
- W911QY18C0004
- Cdrl B002 - Monthly Status Reports Yr 1
- 31 Jan 2019
- Cdrl B002 - Monthly Status Reports Yr 1
- W6qk Acc-Apg Natick
- Department Of Defense (Dod)
- $999,998.10
- Department Of Defense (Dod)
- W911QY18C0004
- Igf::Ot::Igf R&D Exempt
- 14 Nov 2017
- Igf::Ot::Igf R&D Exempt
- W6qk Acc-Apg Natick
- Department Of Defense (Dod)
- $999,998.10
- Department Of Defense (Dod)
- W911QY16P0229
- Igf::Ot::Igf
- 10 Aug 2017
- Igf::Ot::Igf
- W6qk Acc-Apg Natick
- Department Of Defense (Dod)
- $149,656.59
- Department Of Defense (Dod)
- 75N91018C00031
- Igf::Ot::Igf Project Title: Monoclonal Antibodies To Rna-Modifications
- 12 Jun 2019
- Igf::Ot::Igf Project Title: Monoclonal Antibodies To Rna-Modifications
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $299,999.00
- Department Of Health And Human Services (Hhs)
- W911QY18C0004
- Option Year - 2
- 27 Feb 2019
- Option Year - 2
- W6qk Acc-Apg Natick
- Department Of Defense (Dod)
- $999,998.10
- Department Of Defense (Dod)
- 75N91018C00031
- Igf::Ot::Igf Monoclonal Antibodies To Rna-Modifications (Moonshot)
- 5 Sep 2018
- Igf::Ot::Igf Monoclonal Antibodies To Rna-Modifications (Moonshot)
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $299,999.00
- Department Of Health And Human Services (Hhs)
- W911QY18C0004
- Option Year - 2
- 10 Dec 2019
- Option Year - 2
- W6qk Acc-Apg Natick
- Department Of Defense (Dod)
- $999,998.10
- Department Of Defense (Dod)